Wird geladen...
Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
It is time for those working on oncolytic viruses to take stock of the status of the field. We now have at our disposal an array of potential therapeutic agents, and are beginning to conduct early-phase clinical trials in patients with relapsed/metastatic cancers. By drawing on lessons learned durin...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Ltd.
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3915505/ https://ncbi.nlm.nih.gov/pubmed/20223697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cytogfr.2010.02.006 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|